Evidence Report Now Available

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents(Systematic Review, released 1/25/2018)
Selected Key Messages:

Evidence was insufficient on imaging or electroencephalogram to diagnose ADHD in children 7–17 years of age.
Little evidence adds to the 2011 report that found that methylphenidate is effective for children under age 6 with ADHD and that psychostimulants can be effective for children 6–12 years of age.
Atomoxetine had slightly higher gastrointestinal effects than methylphenidate.
Cognitive behavioral therapy may improve ADHD symptoms among children 7–17 years of age.
Child or parent training improved ADHD symptoms among children 7–17 years of age but did not change academic performance.
Omega-3/6 supplementation made no difference in ADHD symptoms.
Future studies are needed to evaluate diagnosis, monitoring, and long-term outcomes for children and adolescents with ADHD managed in usual care settings.

Opportunity to Comment on Draft Key Questions

We encourage the public to participate in the development of our research projects. Comments can be submitted for:

Antipsychotics for the Treatment and Prevention of Delirium
Available for comment until February 16, 2018

Chronic Obstructive Pulmonary Disease Exacerbation
Available for comment until February 16, 2018

About us: AHRQ’s Effective Health Care Program is committed to providing the best available evidence on the outcomes, benefits and harms, and appropriateness of drugs, devices, and health care services and by helping health care professionals, patients, policymakers, and health care systems make informed health care decisions. The program partners with research centers, academic institutions, health professional societies, consumer organizations, and other stakeholders to conduct research, evidence synthesis, evidence translation, dissemination, and implementation of research findings.

To learn more: https://www.effectivehealthcare.ahrq.gov
Contact us at epc@ahrq.hhs.gov

EHC Program Update: Attention Deficit Hyperactivity Disorder Final Report; COPD and Treatment and Prevention of Delirium Draft Key Questions